Wanbangde Pharmaceutical Holding Group (002082) Stock Overview
Wanbangde Pharmaceutical Holding Group Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
002082 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Wanbangde Pharmaceutical Holding Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.11 |
| 52 Week High | CN¥16.66 |
| 52 Week Low | CN¥4.82 |
| Beta | 0.87 |
| 1 Month Change | -16.60% |
| 3 Month Change | 17.57% |
| 1 Year Change | 81.83% |
| 3 Year Change | 11.82% |
| 5 Year Change | -9.76% |
| Change since IPO | 195.82% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Wanbangde Pharmaceutical Holding Group (SZSE:002082) Is Using Debt Extensively
Dec 31
Estimating The Intrinsic Value Of Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE:002082)
Dec 04Wanbangde Pharmaceutical Holding Group's (SZSE:002082) Solid Earnings May Rest On Weak Foundations
Nov 05What Wanbangde Pharmaceutical Holding Group Co., Ltd.'s (SZSE:002082) 38% Share Price Gain Is Not Telling You
Oct 21Shareholder Returns
| 002082 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.0% | -0.6% | 0.5% |
| 1Y | 81.8% | 10.2% | 13.6% |
Return vs Industry: 002082 exceeded the CN Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: 002082 exceeded the CN Market which returned 16% over the past year.
Price Volatility
| 002082 volatility | |
|---|---|
| 002082 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 4.4% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 002082's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 002082's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 1,499 | Shouming Zhao | www.wepon.com.cn |
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business.
Wanbangde Pharmaceutical Holding Group Co., Ltd. Fundamentals Summary
| 002082 fundamental statistics | |
|---|---|
| Market cap | CN¥7.41b |
| Earnings (TTM) | CN¥14.20m |
| Revenue (TTM) | CN¥1.39b |
Is 002082 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002082 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.39b |
| Cost of Revenue | CN¥897.71m |
| Gross Profit | CN¥488.87m |
| Other Expenses | CN¥474.66m |
| Earnings | CN¥14.20m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.023 |
| Gross Margin | 35.26% |
| Net Profit Margin | 1.02% |
| Debt/Equity Ratio | 32.6% |
How did 002082 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/11 00:16 |
| End of Day Share Price | 2025/12/11 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wanbangde Pharmaceutical Holding Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.